Ibuprofen with or without an antiemetic for acute migraine headaches in adults

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 9, 2013, Pages

  Rabbie, Roy ^a   Derry, Sheena ^b   Moore, R Andrew ^b  

^a EPSOM AND ST HELIER UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIEMETIC AGENT; IBUPROFEN; PLACEBO; ROFECOXIB; ANALGESIC AGENT;

ABDOMINAL PAIN; ADULT; ANALGESIA; COMPARATIVE EFFECTIVENESS; DIZZINESS; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG SELF ADMINISTRATION; HUMAN; MIGRAINE; NAUSEA; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SINGLE DRUG DOSE; SOMNOLENCE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; DRUG COMBINATION; META ANALYSIS; METHODOLOGY; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADMINISTRATION, ORAL; ADULT; ANALGESICS, NON-NARCOTIC; ANTIEMETICS; DRUG THERAPY, COMBINATION; HUMANS; IBUPROFEN; MIGRAINE DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84886842932     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008039.pub3     Document Type: Review

References (61)

1. Codispoti JR, Prior MJ, Fu M, Harte CM, Nelson EB. Efficacy of nonprescription doses of ibuprofen for treating migraine headache. A randomized controlled trial. Headache 2001;41(7):665-79. [DOI: 10.1046/j.1526-4610.2001.041007665.x]2633178
2. Diener HC, Bussone G, de Liano H, Eikermann A, Englert R, Floeter T, et al. The EMSASI Study Group. Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks. Cephalalgia 2004;24(11):947-54. [DOI: 10.1111/j.1468-2982.2004.00783.x]2633180
3. Ellis GL, Delaney J, DeHart DA, Owens A. The efficacy of metoclopramide in the treatment of migraine headache. Annals of Emergency Medicine 1993;22(2):191-5. [DOI: 10.1016/S0196-0644(05)80201-X]2633182
4. Goldstein J, Silberstein SD, Saper JR, Ryan RE Jr, Lipton RB. Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study. Headache 2006;46(3):444-53. [DOI: 10.1111/j.1526-4610.2006.00376.x]2633184
5. Kellstein DE, Lipton RB, Geetha R, Koronkiewicz K, Evans FT, Stewart WF, et al. Evaluation of a novel solubulized formulation of ibuprofen in the treatment of migraine headache: a randomized, double blind, placebo-controlled, dose-ranging study. Cephalagia 2001;20(4):233-43. [DOI: 10.1046/j.1468-2982.2000.00055.x]2633186
6. Misra UK, Jose M, Kalita J. Rofecoxib versus ibuprofen for acute treatment of migraine:a randomised placebo controlled trial. Postgraduate Medical Journal 2004;80(950):720-3. [DOI: 10.1136/pgmj.2003.012393]2633188
7. Misra UK, Kalita J, Yadav RK. Rizatriptan vs. ibuprofen in migraine:a randomised placebo-controlled trial. Journal of Headache and Pain 2007;8(3):175-9. [DOI: 10.1007/s10194-007-0386-7]2633190
8. Sandrini G, Franchini S, Lanfranchi S, Granella F, Manzoni GC, Nappi G. Effectiveness of ibuprofen-arginine in the treatment of acute migraine attacks. International Journal of Clinical Pharmacology Research 1998;18(3):145-51. [PUBMED: 9825271]2633192
9. Saper J, Dahlof C, So Y, Tfelt-Hansen P, Malbecq W, Loeys T, et al. Rofecoxib in the acute treatment of migraine: A randomized controlled clinical trial. Headache 2006;46(2):264-75. [DOI: 10.1111/j.1526-4610.2006.00334.x]2633194
10. Havanka-Kanniainen H. Treatment of acute migraine attack: ibuprofen and placebo compared. Headache 1989;29(8):507-9. 2633196
11. Kalita J, Yadav RK, Misra UK. A comparison of migraine patients with and without allodynic symptoms. Clin J Pain 2009;25(8):696-8. 2633198
12. Kloster R, Nestvold K, Vilming ST. A double-blind study of ibuprofen versus placebo in the treatment of acute migraine attacks. Cephalalgia 1992;12(3):169-71. 2633200
13. Nebe J, Heier H, Diener HC. Low-dose ibuprofen in self-medication of mild to moderate headache: a comparison with acetylsalicylic acid and placebo. Cephalalgia 1995;15(6):531-5. 2633202
14. Pearce I, Frank GJ, Pearce JM. Ibuprofen compared with paracetamol in migraine. The Practioner 1983;227(1377):465-7. 2633204
15. Ayzenberg I, Katsarava Z, Sborowski A, Chernysh M, Osipova V, Tabeeva G, et al. The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia 2012;32(5):373-81. [DOI: 10.1177/0333102412438977]
16. Bigal ME, Serrano D, Reed M, Lipton RB. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology 2008;71(8):559-66. [DOI: 10.1212/01.wnl.0000323925.29520.e7]
17. Bloudek LM, Stokes M, Buse DC, Wilcox TK, Lipton RB, Goadsby PJ, et al. Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS). Journal of Headache and Pain 2012;13(5):361-78. [DOI: 10.1007/s10194-012-0460-7]
18. Bulley S, Derry S, Moore RA, McQuay HJ. Single dose oral rofecoxib for acute postoperative pain in adults. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD004604.pub3]
19. Buse D, Manack A, Serrano D, Reed M, Varon S, Turkel C, et al. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study. Headache 2012;52(1):3-17. [DOI: 10.1111/j.1526-4610.2011.02046.x]
20. Collins SL, Moore RA, McQuay HJ. The visual analogue pain intensity scale: what is moderate pain in millimetres?. Pain 1997;72(1-2):95-7.
21. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995;310(6977):452-4.
22. Derry C, Derry S, Moore RA, McQuay HJ. Single dose oral ibuprofen for acute postoperative pain in adults. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD001548.pub2]
23. Derry C, Derry S, Moore A. Sumatriptan (oral route of administration) for acute migraine attacks in adults. Cochrane Database of Systematic Reviews 2012;2:CD008615. [DOI: 10.1002/14651858.CD008615.pub2]
24. Derry S, Rabbie R, Moore RA. Diclofenac with or without an antiemetic for acute migraine headaches in adults. Cochrane Database of Systematic Reviews 2013, Issue 4. [DOI: 10.1002/14651858.CD008783.pub3]
25. Derry S, Moore RA, McQuay HJ. Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults. Cochrane Database of Systematic Reviews 2013;4:CD008040. [DOI: 10.1002/14651858.CD008040.pub3]
26. Diamond S, Bigal ME, Silberstein S, Loder E, Reed M, Lipton RB. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study. Headache 2007;47(3):355-63. [DOI: 10.1111/j.1526-4610.2006.00631.x]
27. Friedman BW, Corbo J, Lipton RB, Bijur PE, Esses D, Solorzano C, et al. A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines. Neurology 2005;64(3):463-8. [DOI: 10.1212/01.WNL.0000150904.28131.DD]
28. Gendolla A. Early treatment in migraine: how strong is the current evidence?. Cephalalgia 2008;28 Suppl 2:28-35. [DOI: 10.1111/j.1468-2982.2008.01688.x]
29. Hazard E, Munakata J, Bigal ME, Rupnow MF, Lipton RB. The burden of migraine in the United States: current and emerging perspectives on disease management and economic analysis. Value in Health 2009;12(1):55-64. [DOI: 10.1111/j.1524-4733.2008.00404.x]
30. Higgins JPT, Green S (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Altman DG, Sterne JAC editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
31. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8 Suppl 7:1-96.
32. International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia 2000;20(9):765-86.
33. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24 Suppl 1:1-160.
34. Jadad AR, Carroll D, Moore A, McQuay H. Developing a database of published reports of randomised clinical trials in pain research. Pain 1996;66(2-3):239-46.
35. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17(1):1-12.
36. Kirthi V, Derry S, Moore RA, McQuay HJ. Aspirin with or without an antiemetic for acute migraine headaches in adults. Cochrane Database of Systematic Reviews 2013, Issue 4. [DOI: 10.1002/14651858.CD008041.pub3]
37. L'Abbé KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Annals of Internal Medicine 1987;107(2):224-33.
38. Leonardi M, Steiner TJ, Scher AT, Lipton RB. The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF). Journal of Headache and Pain 2005;6(6):429-40. [DOI: 10.1007/s10194-005-0252-4]
39. Linde M, Gustavsson A, Stovner LJ, Steiner TJ, Barré J, Katsarava Z, et al. The cost of headache disorders in Europe: the Eurolight project. European Journal of Neurology 2012;19(5):703-11. [DOI: 10.1111/j.1468-1331.2011.03612.x]
40. Lipton RB, Stewart WF. Acute migraine therapy: do doctors understand what patients with migraine want from therapy?. Headache 1999;39 Suppl 2:S20-S26.
41. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, AMPP Advisory Group, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68(5):343-9. [PUBMED: 17261680]
42. Lucas C, Géraud G, Valade D, Chautard MH, Lantéri-Minet M. Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French nationwide population-based survey. Headache 2006;46(5):715-25. [DOI: 10.1111/j.1526-4610.2006.00430.x]
43. Moore RA, Gavaghan D, Tramer MR, Collins SL, McQuay HJ. Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain 1998;78(3):209-16. [DOI: 10.1016/S0304-3959(98)00140-7]
44. Moore RA, Barden J, Derry S, McQuay HJ. Managing potential publication bias. In: McQuay HJ, Kalso E, Moore RA editor(s). Systematic Reviews in Pain Research: Methodology Refined. Seattle: IASP Press, 2008:15-24. [ISBN: 978-0-931092-69-5]
45. Morris JA, Gardner MJ. Calculating confidence intervals for relative risk, odds ratios and standardised ratios and rates. In: Gardner MJ, Altman DG editor(s). Statistics with confidence - confidence intervals and statistical guidelines. London: British Medical Journal, 1995:50-63.
46. Munakata J, Hazard E, Serrano D, Klingman D, Rupnow MF, Tierce J, et al. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache 2009;49(4):498-508. [DOI: 10.1111/j.1526-4610.2009.01369.x]
47. Oldman AD, Smith LA, McQuay HJ, Moore RA. Pharmacological treatments for acute migraine: quantitative systematic review. Pain 2002;97(3):247-57. [DOI: 10.1016/S0304-3959(02)00024-6]
48. Radtke A, Neuhauser H. Prevalence and burden of headache and migraine in Germany. Headache 2009;49(1):79-89. [DOI: 10.1111/j.1526-4610.2008.01263.x]
49. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
50. Ross-Lee LM, Eadie MJ, Heazlewood V, Bochner F, Tyrer JH. Aspirin pharmacokinetics in migraine. The effect of metoclopramide. European Journal of Clinical Pharmacology 1983;24(6):777-85.
51. Salazar-Tortolero G, Huertas-Campistol A, Vergez-Pinto L, Ramos-Brunet A, Lluch-López J. Metoclopramide as a painkiller for intense migraine headache in emergency departments [Metoclopramida como analgésicoen la cefalea migrañosa intensa en urgencias]. Revista de Neurologia 2008;47(10):506-8. [PUBMED: 19012253]
52. Steiner TS, Stovner LJ, Birbeck GL. Migraine: the seventh disabler. Journal of Headache and Pain 2013;14:1. [DOI: 10.1186/1129-2377-14-1]
53. Stovner LJ, Andree C. Prevalence of headache in Europe: a review for the Eurolight project. Journal of Headache and Pain 2010;11(4):289-99. [DOI: 10.1007/s10194-010-0217-0]
54. Suthisisang C, Poolsup N, Kittikulsuth W, Pudchakan P, Wiwatpanich P. Efficacy of low-dose ibuprofen in acute migraine treatment: systematic review and meta-analysis. Annals of Pharmacotherapy 2007;41(11):1782-91. [DOI: 10.1345/aph.1K121]
55. Tramèr MR, Reynolds DJM, Moore RA, McQuay HJ. Impact of covert duplicate results on meta-analysis: a case study. BMJ 1997;315(7109):635-9.
56. Victor TW, Hu X, Campbell JC, Buse DC, Lipton RB. Migraine prevalence by age and sex in the United States: a life-span study. Cephalalgia 2010;30(9):1065-72.
57. Volans GN. Absorption of effervescent aspirin during migraine. British Medical Journal 1974;4(5939):265-8.
58. Volans GN. The effect of metoclopramide on the absorption of effervescent aspirin in migraine. British Journal of Clinical Pharmacology 1975;2(1):57-63.
59. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380(9859):2163-96. [DOI: 1016/S0140-6736(12)61729-2]
60. Yu S, Liu R, Zhao G, Yang X, Qiao X, Feng J, et al. The prevalence and burden of primary headaches in China: a population-based door-to-door survey. Headache 2012;52(4):582-91. [DOI: 10.1111/j.1526-4610.2011.02061.x]
61. Rabbie R, Derry S, Moore RA, McQuay HJ. Ibuprofen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database of Systematic Reviews 2010, Issue 10. [DOI: 10.1002/14651858.CD008039.pub2]